Anastasia Giachali

Anastasia Giachali is currently the Global Value Strategy & Payer Engagement Lead at Novo Nordisk, a prominent global healthcare company known for its focus on diabetes care and other chronic diseases. In her role, she is responsible for optimizing market access strategies and generating payer-relevant real-world evidence to support innovative solutions within the company.

Educational Background

Anastasia holds a degree from Copenhagen Business School, which has equipped her with a solid foundation in business and management principles relevant to the healthcare sector.

Professional Experience

Before joining Novo Nordisk, Anastasia has garnered extensive experience in the pharmaceutical and healthcare industries. Her LinkedIn profile indicates that she has held various roles that emphasize market access and payer engagement, which are critical in ensuring that new therapies reach patients effectively.

Skills and Expertise

Anastasia is recognized for her expertise in:

• Market Access Strategies: Developing approaches to ensure that products are accessible to patients.
• Payer Engagement: Building relationships with payers to facilitate the adoption of new therapies.
• Real-World Evidence Generation: Utilizing data from real-world settings to support product value propositions.

With over 500 connections on LinkedIn, Anastasia is actively engaged in her professional community, sharing insights and developments related to healthcare market access and payer strategies.